Medical Consultation

Dare to Share

     We combine the best of what Israel can offer to the world: people, biotech, agritech, and science - to make natural remedies and wellness products available while providing employment for local communities and effective returns to our investors

Amit SadeFounder, CEO

About Sadé

Sadé Group is geared to be a global leader in bringing innovative pharma-grade cannabis products to market . The company was founded as a leading scientific research company with its initial projects focusing on cannabis cultivation, as well as genetic and applied research, by scientists at the ARO, Israel’s government Agricultural Research Organization

Pharma-grade Cannabis Products

Genetic Research & Big Data Mapping

Advanced Agriculture & Breeding Technologies

The company expanded on its knowledge of growing for research purposes – and upscaled it to include clinical research and GMP manufacturing for multiple industries

 Sadé Global Reach       

FROM PLANT GENETICS TO CLINICAL STUDIES

Checking Blood Pressure

CANNABIS IN NUMBERS

AN INDUSTRY READY TO BLOOM

$67
Bn

Medical cannabis global market 2020

40+
Patents

Sade 2019: number of registered patents on genes, strains, varieties and medical products

$146
Bn

Legal marijuana market in 2025

7.8
Tonnes

Sadé GAP/GMP certified medical cannabis yield in 2020

Medical Consultation

8 Sapir Street

Science Park, Nes Ziona

Israel

contact@sade.group

© 2020 by Sade Group